33.09 USD
+0.87 (+2.7%)
32.9083 USD
-0.18 (-0.55%)
Taking everything into account, OPCH scores 6 out of 10 in our fundamental rating. OPCH was compared to 100 industry peers in the Health Care Providers & Services industry. While OPCH has a great profitability rating, there are some minor concerns on its financial health. OPCH has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
OPCH had positive earnings in the past year.
OPCH had a positive operating cash flow in the past year.
Of the past 5 years OPCH 4 years were profitable.
Each year in the past 5 years OPCH had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 6.01%, OPCH belongs to the best of the industry, outperforming 84.00% of the companies in the same industry.
OPCH has a better Return On Equity (15.39%) than 81.00% of its industry peers.
OPCH has a better Return On Invested Capital (9.36%) than 78.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OPCH is in line with the industry average of 9.44%.
The 3 year average ROIC (8.38%) for OPCH is below the current ROIC(9.36%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.01% | ||
| ROE | 15.39% | ||
| ROIC | 9.36% |
ROA(3y)6.44%
ROA(5y)4.81%
ROE(3y)14.91%
ROE(5y)11.17%
ROIC(3y)8.38%
ROIC(5y)7%
1.3 Margins
The Profit Margin of OPCH (3.78%) is better than 73.00% of its industry peers.
In the last couple of years the Profit Margin of OPCH has remained more or less at the same level.
OPCH has a Operating Margin of 6.03%. This is in the better half of the industry: OPCH outperforms 67.00% of its industry peers.
In the last couple of years the Operating Margin of OPCH has grown nicely.
The Gross Margin of OPCH (19.41%) is comparable to the rest of the industry.
OPCH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.03% | ||
| PM (TTM) | 3.78% | ||
| GM | 19.41% |
OM growth 3Y5.08%
OM growth 5Y42.3%
PM growth 3Y1.37%
PM growth 5YN/A
GM growth 3Y-3.67%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
OPCH has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, OPCH has less shares outstanding
The number of shares outstanding for OPCH has been reduced compared to 5 years ago.
The debt/assets ratio for OPCH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.84 indicates that OPCH is not in any danger for bankruptcy at the moment.
The Altman-Z score of OPCH (3.84) is better than 76.00% of its industry peers.
OPCH has a debt to FCF ratio of 5.28. This is a neutral value as OPCH would need 5.28 years to pay back of all of its debts.
The Debt to FCF ratio of OPCH (5.28) is better than 65.00% of its industry peers.
OPCH has a Debt/Equity ratio of 0.85. This is a neutral value indicating OPCH is somewhat dependend on debt financing.
OPCH's Debt to Equity ratio of 0.85 is in line compared to the rest of the industry. OPCH outperforms 44.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.28 | ||
| Altman-Z | 3.84 |
ROIC/WACC1.08
WACC8.64%
2.3 Liquidity
A Current Ratio of 1.56 indicates that OPCH should not have too much problems paying its short term obligations.
OPCH has a Current ratio (1.56) which is in line with its industry peers.
OPCH has a Quick Ratio of 1.05. This is a normal value and indicates that OPCH is financially healthy and should not expect problems in meeting its short term obligations.
OPCH has a Quick ratio of 1.05. This is in the lower half of the industry: OPCH underperforms 61.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 25.21% over the past year.
OPCH shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.58% yearly.
Looking at the last year, OPCH shows a quite strong growth in Revenue. The Revenue has grown by 15.79% in the last year.
OPCH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.69% yearly.
EPS 1Y (TTM)25.21%
EPS 3Y16.58%
EPS 5YN/A
EPS Q2Q%45.16%
Revenue 1Y (TTM)15.79%
Revenue growth 3Y13.28%
Revenue growth 5Y16.69%
Sales Q2Q%12.24%
3.2 Future
Based on estimates for the next years, OPCH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.80% on average per year.
The Revenue is expected to grow by 9.78% on average over the next years. This is quite good.
EPS Next Y43.64%
EPS Next 2Y25.07%
EPS Next 3Y20.99%
EPS Next 5Y18.8%
Revenue Next Year14.13%
Revenue Next 2Y10.73%
Revenue Next 3Y10.17%
Revenue Next 5Y9.78%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 22.21, which indicates a rather expensive current valuation of OPCH.
67.00% of the companies in the same industry are more expensive than OPCH, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of OPCH to the average of the S&P500 Index (26.59), we can say OPCH is valued inline with the index average.
A Price/Forward Earnings ratio of 17.34 indicates a rather expensive valuation of OPCH.
68.00% of the companies in the same industry are more expensive than OPCH, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.80. OPCH is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.21 | ||
| Fwd PE | 17.34 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OPCH is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as OPCH.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.89 | ||
| EV/EBITDA | 14.89 |
4.3 Compensation for Growth
OPCH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OPCH has a very decent profitability rating, which may justify a higher PE ratio.
OPCH's earnings are expected to grow with 20.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y25.07%
EPS Next 3Y20.99%
5. Dividend
5.1 Amount
OPCH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
33.09
+0.87 (+2.7%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners106.67%
Inst Owner Change2.82%
Ins Owners0.74%
Ins Owner Change6.48%
Market Cap5.25B
Revenue(TTM)5.53B
Net Income(TTM)209.08M
Analysts84.71
Price Target35.7 (7.89%)
Short Float %4.79%
Short Ratio3.49
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.21%
Min EPS beat(2)2.6%
Max EPS beat(2)3.83%
EPS beat(4)3
Avg EPS beat(4)-0.18%
Min EPS beat(4)-9.25%
Max EPS beat(4)3.83%
EPS beat(8)6
Avg EPS beat(8)3.33%
EPS beat(12)9
Avg EPS beat(12)19.17%
EPS beat(16)12
Avg EPS beat(16)19.2%
Revenue beat(2)1
Avg Revenue beat(2)1.1%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.61%
Revenue beat(4)3
Avg Revenue beat(4)2.18%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)4.14%
Revenue beat(8)7
Avg Revenue beat(8)2.21%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)1.34%
PT rev (1m)-7.08%
PT rev (3m)-9.09%
EPS NQ rev (1m)-0.07%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)0.23%
EPS NY rev (3m)0.66%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.21 | ||
| Fwd PE | 17.34 | ||
| P/S | 0.95 | ||
| P/FCF | 23.89 | ||
| P/OCF | 20.31 | ||
| P/B | 3.87 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.89 |
EPS(TTM)1.49
EY4.5%
EPS(NY)1.91
Fwd EY5.77%
FCF(TTM)1.39
FCFY4.19%
OCF(TTM)1.63
OCFY4.92%
SpS34.84
BVpS8.56
TBVpS-3.57
PEG (NY)0.51
PEG (5Y)N/A
Graham Number16.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.01% | ||
| ROE | 15.39% | ||
| ROCE | 12.55% | ||
| ROIC | 9.36% | ||
| ROICexc | 10.6% | ||
| ROICexgc | 59.05% | ||
| OM | 6.03% | ||
| PM (TTM) | 3.78% | ||
| GM | 19.41% | ||
| FCFM | 3.98% |
ROA(3y)6.44%
ROA(5y)4.81%
ROE(3y)14.91%
ROE(5y)11.17%
ROIC(3y)8.38%
ROIC(5y)7%
ROICexc(3y)9.71%
ROICexc(5y)7.89%
ROICexgc(3y)58.03%
ROICexgc(5y)47.49%
ROCE(3y)11.24%
ROCE(5y)9.38%
ROICexgc growth 3Y17%
ROICexgc growth 5Y65.46%
ROICexc growth 3Y18.73%
ROICexc growth 5Y65.49%
OM growth 3Y5.08%
OM growth 5Y42.3%
PM growth 3Y1.37%
PM growth 5YN/A
GM growth 3Y-3.67%
GM growth 5Y-1.81%
F-Score5
Asset Turnover1.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.85 | ||
| Debt/FCF | 5.28 | ||
| Debt/EBITDA | 2.88 | ||
| Cap/Depr | 57.38% | ||
| Cap/Sales | 0.7% | ||
| Interest Coverage | 5.09 | ||
| Cash Conversion | 64.51% | ||
| Profit Quality | 105.17% | ||
| Current Ratio | 1.56 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 3.84 |
F-Score5
WACC8.64%
ROIC/WACC1.08
Cap/Depr(3y)59.17%
Cap/Depr(5y)49.85%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.84%
Profit Quality(3y)137.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.21%
EPS 3Y16.58%
EPS 5YN/A
EPS Q2Q%45.16%
EPS Next Y43.64%
EPS Next 2Y25.07%
EPS Next 3Y20.99%
EPS Next 5Y18.8%
Revenue 1Y (TTM)15.79%
Revenue growth 3Y13.28%
Revenue growth 5Y16.69%
Sales Q2Q%12.24%
Revenue Next Year14.13%
Revenue Next 2Y10.73%
Revenue Next 3Y10.17%
Revenue Next 5Y9.78%
EBIT growth 1Y4.3%
EBIT growth 3Y19.04%
EBIT growth 5Y66.04%
EBIT Next Year39.31%
EBIT Next 3Y17.14%
EBIT Next 5Y13.01%
FCF growth 1Y-32.01%
FCF growth 3Y16.29%
FCF growth 5Y91.41%
OCF growth 1Y-28.91%
OCF growth 3Y15.74%
OCF growth 5Y52.27%
OPTION CARE HEALTH INC / OPCH FAQ
What is the ChartMill fundamental rating of OPTION CARE HEALTH INC (OPCH) stock?
ChartMill assigns a fundamental rating of 6 / 10 to OPCH.
What is the valuation status for OPCH stock?
ChartMill assigns a valuation rating of 5 / 10 to OPTION CARE HEALTH INC (OPCH). This can be considered as Fairly Valued.
Can you provide the profitability details for OPTION CARE HEALTH INC?
OPTION CARE HEALTH INC (OPCH) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for OPCH stock?
The Earnings per Share (EPS) of OPTION CARE HEALTH INC (OPCH) is expected to grow by 43.64% in the next year.